MediWound (MDWD) EV to FCF (2014 - 2026)
MediWound (MDWD) posted EV to FCF of 19.04 for Q2 2026, up 50.92% on a QoQ basis from 38.8 in Q1 2026, and up 49.26% year-over-year from 12.76 in Q2 2025.
Analysis
MediWound (MDWD) EV to FCF (2014 - 2026) Analysis & Trends
MediWound has reported EV to FCF for 13 years, with the latest figure at 19.04 in Q2 2026.
- On a quarterly basis, EV to FCF rose 49.26% year-over-year to 19.04 in Q2 2026; TTM through Jun 2026 was 9.74, a 37.95% increase from a year earlier, with the FY2025 full-year figure at 17.31, up 14.56% from the prior year.
- EV to FCF was 19.04 for Q2 2026 at MediWound, up from 38.8 in the prior quarter.
- The five-year high for EV to FCF was 244.79 in Q3 2022, with the low at 325.88 in Q4 2025.
- Average EV to FCF over 5 years is 46.21, with a median of 37.68 recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: EV to FCF surged 825.03% in 2022, then plunged 38403.22% in 2024.
- Over 5 years, EV to FCF stood at 36.13 in 2022, then slumped by 455.06% to 128.27 in 2023, then tumbled by 39.74% to 179.25 in 2024, then slumped by 81.8% to 325.88 in 2025, then jumped by 94.16% to 19.04 in 2026.
- The last three EV to FCF figures came in at 19.04 (Q2 2026), 38.8 (Q1 2026), and 325.88 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.04 |
| Mar 31, 2026 | -38.80 |
| Dec 31, 2025 | -325.88 |
| Sep 30, 2025 | -61.71 |
| Jun 30, 2025 | -37.52 |
| Mar 31, 2025 | -52.73 |
| Dec 31, 2024 | -179.25 |
| Sep 30, 2024 | -47.19 |
| Jun 30, 2024 | -187.66 |
| Mar 31, 2024 | -37.84 |
| Dec 31, 2023 | -128.27 |
| Sep 30, 2023 | 18.33 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | 4.28 |
| Dec 31, 2022 | 36.13 |
| Sep 30, 2022 | 244.79 |
| Jun 30, 2022 | -9.29 |
| Mar 31, 2022 | -9.63 |
| Dec 31, 2021 | -25.16 |
| Sep 30, 2021 | -33.76 |